These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3940680)

  • 1. Some clinical implications of the results of the Lipid Research Clinics Program Prevalence Study.
    LaRosa JC; Levy RI; Hazzard WR
    Circulation; 1986 Jan; 73(1 Pt 2):I126-33. PubMed ID: 3940680
    [No Abstract]   [Full Text] [Related]  

  • 2. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.
    Segal P; Insull W; Chambless LE; Stinnett S; LaRosa JC; Weissfeld L; Halfon S; Kwiterovitch PO; Little JA
    Circulation; 1986 Jan; 73(1 Pt 2):I108-18. PubMed ID: 3940677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improved diagnosis of lipoproteins with vasoprotective and vasoaggresive properties].
    Mertz DP
    Lebensversicher Med; 1979 Nov; 31(6):151-5. PubMed ID: 44336
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipoproteinemias and manifestations of coronary heart disease. The Lipid Research Clinics Program Prevalence Study.
    Rubenstein C; Romhilt D; Segal P; Heiss G; Chambless LE; Boyle KE; Ekelund LG; Adolph R; Sheffield LT
    Circulation; 1986 Jan; 73(1 Pt 2):I91-9. PubMed ID: 3940687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study.
    Pomrehn P; Duncan B; Weissfeld L; Wallace RB; Barnes R; Heiss G; Ekelund LG; Criqui MH; Johnson N; Chambless LE
    Circulation; 1986 Jan; 73(1 Pt 2):I100-7. PubMed ID: 3940676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disorders of lipid transport--update 1983.
    Schonfeld G
    Prog Cardiovasc Dis; 1983; 26(2):89-108. PubMed ID: 6312486
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study.
    Criqui MH; Cowan LD; Heiss G; Haskell WL; Laskarzewski PM; Chambless LE
    Circulation; 1986 Jan; 73(1 Pt 2):I40-50. PubMed ID: 3940683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of lipoprotein disorders.
    Stacpoole P
    Compr Ther; 1989 Apr; 15(4):28-44. PubMed ID: 2650981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the effect of migration to high-mountain regions on the blood lipoprotein system].
    Aĭtbaev KA; Madaminov IaK; Meĭmanaliev TS; Shleĭfer EA; Kim NM
    Kosm Biol Aviakosm Med; 1990; 24(6):45-6. PubMed ID: 2149868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update on dyslipoproteinemias and their role in changes in the statoacoustic apparatus].
    Pallestrini EA; Borasi F
    Ann Laringol Otol Rinol Faringol; 1978; 76(3):239-76. PubMed ID: 233339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperlipidemia in hemodialysis patients].
    Nishikawa O; Mune M; Yukawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():753-7. PubMed ID: 11347168
    [No Abstract]   [Full Text] [Related]  

  • 13. Lp(a) and the risk of coronary heart disease.
    Bihari-Varga M; Kostner G; Czinner A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():33-5. PubMed ID: 1387093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indicators of the atherogenic properties of plasma lipoproteins and coronary atherosclerosis (selective angiography data)].
    Perova NV; Shcherbakova IA; Nechaev AS; Nikitina NA; Metel'skaia VA
    Kardiologiia; 1985 Oct; 25(10):91-5. PubMed ID: 4087659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of known risk factors on the lipoprotein profile.
    Seidel D; Cremer P
    Monogr Atheroscler; 1986; 14():150-3. PubMed ID: 3736555
    [No Abstract]   [Full Text] [Related]  

  • 16. Current therapy for hypercholesterolemia.
    Blum CB; Levy RI
    JAMA; 1989 Jun 23-30; 261(24):3582-7. PubMed ID: 2657125
    [No Abstract]   [Full Text] [Related]  

  • 17. Classification of primary dyslipoproteinemias.
    Dargel R
    Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651
    [No Abstract]   [Full Text] [Related]  

  • 18. [High density lipoproteins of the blood plasma and dysalphalipoproteinemia (a review)].
    Polikarpova LI
    Vopr Med Khim; 1981; 27(5):579-90. PubMed ID: 7032061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence and characteristics of dyslipoproteinemia in men with ischemic heart disease detected in an epidemiologic study].
    Lipovetskiĭ BM; Nikul'cheva NG; Shestov DB; Plavinskaia SI
    Kardiologiia; 1982 Aug; 22(8):23-6. PubMed ID: 7132036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dyslipoproteinemias and coronary disease. Genetic markers].
    Sarriá Chueca A; Moreno Aznar L; Bueno Lozano G; Bueno Sánchez M
    An Esp Pediatr; 1989 Jun; 30(6):425-8. PubMed ID: 2572193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.